New insider activity at MapLight Therapeutics, Inc. ( (MPLT) ) has taken place on October 29, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Catalyst4, Inc., a significant shareholder, has made a substantial investment in MapLight Therapeutics, Inc. by purchasing 5,441,176 shares. This transaction is valued at an impressive $92,499,992.
Recent Updates on MPLT stock
MapLight Therapeutics, Inc. successfully closed its initial public offering (IPO), issuing 14,750,000 shares of common stock at $17.00 per share, with underwriters exercising an option to purchase an additional 2,212,500 shares. The company also completed a private placement with Goldman Sachs affiliates, raising a total of $296.3 million from both the IPO and private placement. This influx of capital is expected to enhance MapLight’s financial position and market presence.
More about MapLight Therapeutics, Inc.